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Abstract
Objective—Survivorship care plans (SCP), which describe a cancer survivor’s diagnosis, 
treatment and follow-up, are recommended. The study objective was to evaluate primary care 
providers’ (PCP) responses to SCPs developed for breast and colorectal cancer survivors in their 
practice and to determine whether PCP response to the SCPs varied according to characteristics of 
the practitioner and their practice.
Method—SCPs were created using the Journey Forward® Care Plan for breast and colorectal 
cancer patients in rural and urban settings. The SCP and a survey were sent to PCPs.
Participants—Primary care physicians.
Main Measures—Attitudes regarding survivorship care plans.
Results—Thirty-nine (70.9% response rate) surveys were completed. Most felt the SCP was 
useful (90%), that it enhanced understanding (75%) and that detail was sufficient (>80%). 
However, 15% disagreed that the care plan helped them understand their role, a perception 
especially prevalent among PCPs in the rural setting. Among PCPs with ≤ 18 years in practice, 
95% agreed that the SCP would improve communication with patients, contrasted with 60% of 
those with >21 years in practice. The most common barrier to providing follow-up care was 
limited access to survivors.
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Conclusions—While SCPs appear to improve PCPs understanding of a cancer diagnosis and 
treatment, clear delineation of each provider’s role in follow-up care is needed. Additional detail 
on which tests are needed and education on late and long term effects of cancer may improve 
coordination of care.
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Introduction
Improvements in cancer screening and therapy have resulted in a growing number of cancer 
survivors. The transition between initial therapy and surveillance has unique challenges [1]. 
Oncology visits often continue but focus on cancer issues and do not include screening for 
other malignancies or general health monitoring. Previous research suggests that when care 
is shared between specialists and primary care providers (PCPs), survivors receive better 
health care [2–4]. Yet, the role of the PCP in survivorship care is often unclear and 
communication is inadequate between the oncologist, PCP and patient [5–7].
The 2005 Institute of Medicine report on cancer survivorship, From Cancer Patient to 
Cancer Survivor: Lost in Transition called for the development of cancer survivor 
documents for survivors and their PCPs [8]. In 2015 the American College of Surgeons 
Commission on Cancer will require a survivorship care plan (SCP) for cancer survivors [9]. 
A SCP has the potential to facilitate communication about the oncology experience. Ideally, 
it provides a clear outline of the diagnosis, treatments received, plan for monitoring and 
clarifies the roles of the medical providers involved in the survivor’s care.
PCPs clearly favor the receipt of a summary of cancer diagnosis and care [6,10] and their 
perceptions of SCPs have been positive [11]. However, there is limited research evaluating 
how PCPs perceive SCPs developed for their own patients. It is also unknown whether the 
needs and preferences of PCPs in different practice settings differ regarding follow up care 
of cancer survivors. We evaluated PCPs’ understanding of and satisfaction with SCPs 
prepared for breast and colorectal cancer survivors in their practice. Additionally we 
examined whether PCP response to the SCPs varied according to characteristics of the 
practitioner and their practice.
Methods
SCPs were developed for breast and colorectal cancer patients and mailed to their PCPs at 
an urban and rural cancer center. In 2010, the urban area had a census of greater than 
150,000, while the rural area had a population of approximately 31,000. All stage 0–3 breast 
cancer and stage 2–4 colorectal cancer patients who received intent to cure oncologic 
interventions between January 2011 and July 2011 were eligible to receive a SCP. A total of 
89 patients were invited to participate in the study and 78 agreed (88%), including 61 with 
breast cancer and 17 with colorectal cancer.
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Document development and delivery
Journey Forward® software was used to create the SCP [12]. The content followed the IOM 
report recommendations to include a summary of cancer type, treatment and treatment 
related complications, recommendations for follow up and the type of provider to see for 
follow up care, information on secondary cancer prevention and health promotion, and local 
resources [8]. Diagnosis and treatment information was obtained from medical records. The 
document was provided to both the cancer survivor and their PCP.
Prior to study initiation two survivor focus groups (one for breast cancer participants, one 
for colorectal cancer participants) were conducted to review sample Journey Forward care 
plans and the explanatory material for SCPs. Focus group participants were recruited from 
the Vermont Cancer Survivor Registry [13]. All focus groups lasted approximately 90 
minutes. Additionally, three PCPs reviewed SCP templates and the survey for ease of use 
and completeness.
The SCP documents were prepared at each cancer center by an advanced practice provider 
(Nurse Practitioner or Physician Assistant) who had training in cancer survivor issues. The 
same practitioner also presented and discussed the SCP with cancer survivors. If 
inconsistencies in the SCP were identified by the patient at the time of the visit the 
information in question was re-examined and corrected in the SCP.
Survivor and PCP recruitment
At the urban center all eligible patients presenting for a first or second post therapy visit 
were informed that their next clinic visit would be an hour long survivorship visit which 
would include usual review of side effects and monitoring and a discussion of the SCP. At 
the visit they were informed of the opportunity to participate in a study to evaluate the SCP. 
If they agreed to participate in the longer visit and receive the document, an informed 
consent was signed. At the rural center patients were approached at the end of initial 
oncologic therapy and asked if they would like to receive a separate survivor visit and SCP. 
If the patient signed consent they were scheduled for a 1 hour long survivor visit 1–3 months 
later (i.e., same time frame as for the urban clinic visit). Several days prior to the visit, 
patients at both sites received a reminder call that the appointment was approaching.
PCP Survey development and administration
A survey was developed by study investigators to evaluate PCPs perceptions of the SCPs 
they received for patients in their care. The survey included the following topics: 
understanding of the patient’s treatment and follow up; adequacy of content detail; 
communication; and barriers to caring for cancer survivors. The survey used a 5-point Likert 
scale with five responses ranging from “Strongly Agree” to “Strongly Disagree”. 
Participants were asked to circle the number corresponding to their level of agreement with 
each statement. Demographic information about their practice was collected.
The SCP was mailed to the PCPs with a cover letter explaining the study, the survey and a 
self-addressed stamped return envelope. The return of the survey implied consent at the 
urban center. At the rural center PCP’s returning the survey also returned a signed IRB 
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approved consent. If a PCP received two SCPs he/she only received a survey with the first 
SCP. If the survey was not returned, two attempts were made to contact the PCP by mail. 
PCPs who did not return the survey within 4–8 weeks were contacted via email by an 
oncologist involved in the study at the urban center, while at the rural center an 
administrative secretary called the PCP.
Statistical analysis
Descriptive statistics were calculated to determine survey response frequencies and the 
distribution of demographic variables. Likert scale responses for strongly agree and agree as 
well as strongly disagree and disagree were collapsed in order to obtain categories with 
sufficient sample sizes for analysis. Descriptive statistics were used to assess differences 
between urban and rural PCPs responses and between those in practice less than or equal to 
and greater than the median of 18 years. Fisher’s exact test was used to identify statistically 
significant (p<0.05) differences according to these factors. All statistical analyses were 
conducted using SAS Statistical Software (Version 9; SAS Institute, Inc., Cary, North 
Carolina).
Results
Of the 55 surveys sent to PCPs, 39 were returned for a response rate of 70.9%. We received 
22 surveys from PCP’s in the urban area and 17 from PCP’s in the rural area. Demographic 
characteristics of respondents are summarized in Table 1. The majority of respondents were 
female and family practice physicians. The demographic characteristics between rural and 
urban centers were similar other than a predominance of female providers in the rural area.
Nearly all PCP's reported that the SCP was easy to understand (97%), incorporated 
appropriate topics (97%) and was useful (90%). However 16% disagreed that the length of 
the SCP (which was on average 5 pages) was "just right". Written comments concurred that 
several PCPs felt the SCP was too long.
Understanding SCP information
Greater than 75% of PCP’s felt the SCP contributed to their understanding of the cancer 
diagnosis, treating team, recommendations for follow up, and resources available for 
survivorship care, with no statistically significant differences between urban and rural sites 
(Table 2).
PCPs in practice >18 years were significantly less likely to endorse that the SCP contributed 
to their understanding of the cancer diagnosis (p-interaction=0.04) and were less likely to 
agree that they understood the follow-up for late or chronic problems resulting from cancer 
treatment (p-interaction=0.02). A proportion of respondents (15%) disagreed that the care 
plan helped them understand their role in facilitating survivorship care and 15% disagreed 
that they understood how responsibility would be shared with the oncologist. The PCPs 
from the rural site were less likely to agree that the SCP contributed to their understanding 
of their role (p-interaction=0.05).
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Adequacy of content detail
The survey assessed whether the level of detail in the SCP was adequate to perform several 
tasks (Table 3). Greater than 80% of respondents agreed that the level of detail was 
sufficient and response was similar for years in practice. However, the rural PCP’s were less 
likely than the urban PCPs to agree that the SCPs provided sufficient detail about 
monitoring for late and long term effects and tests to obtain for monitoring. There was no 
significant difference in the perception of SCP content detail by years in practice.
Communication
Over 70% of PCP’s at each site agreed that SCPs would improve communication with 
medical providers and patients (Table 4).
Perceptions about improved communication with patients were similar among urban and 
rural PCPs, but differed according to years in practice. Among those with ≤ 18 years in 
practice, 95% of PCPs agreed that the SCP would improve communication with patients, 
whereas only 60% of PCPs with >18 years in practice agreed (p-interaction= 0.03). Despite 
general agreement that the SCP was useful, 13% of all respondents either did not care if they 
received SCP documents or did not want to receive them. There was no statistically 
significant difference in desire to receive SCPs by site or years in practice.
Barriers to providing survivorship care identified by PCP's are included in Table 5. The 
most common barrier to providing follow-up care was “limited access to survivors since 
they stay with their oncologist” with 64% considering this a significant or moderate barrier. 
PCP’s practicing for less than 18 years were significantly more likely to feel that insufficient 
knowledge of cancer survivorship issues was a barrier to survivor care (79% vs. 36.8%). 
Overall, only 18% felt that poor reimbursement was a barrier (Table 5).
Discussion
In general, PCP’s felt that SCPs developed for their patients contributed to their 
understanding of the cancer diagnosis and treatment and would improve communication 
with cancer treatment providers and survivors. However, we discovered differences between 
urban and rural PCPs and those in practice less than 18 years compared with those in 
practice longer. We also found that PCPs encounter substantial barriers in providing 
survivorship care.
Our survey results are consistent with a recent study based on semi-structured interviews of 
primary care providers receiving SCPs for their patients who felt SCPs increased their 
knowledge about their patient’s cancer history and recommendations for surveillance [11]. 
There were two notable exceptions regarding the agreement between the two studies: 1) the 
role of PCP and oncologist in survivorship care and; 2) division of responsibility for 
monitoring for recurrence and new primary cancers.
Despite receiving a SCP for a specific patient, many urban and rural PCPs remained unclear 
about their role in survivorship care and how primary care and oncology might share 
responsibility. The rural PCPs were significantly less likely to understand their role in 
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follow up care and continuing education efforts should target them. There is not a defined 
time to transfer the care of a cancer survivor from oncology to primary care. Commonly 
patients continue to see both a PCP and an oncologist for an extended period making it 
difficult to clearly delineate who is responsible for follow up care. As a result, many aspects 
of survivorship follow up may remain ambiguous. Additionally, a majority of PCPs feel that 
primary care guidelines for adult cancer survivors are not well defined [14].
Significant differences have been reported between oncologists and PCPs in the attitudes, 
knowledge and practices for cancer survivor care [15]. PCPs express concern that they do 
not know what surveillance tests are needed or the appropriate duration of surveillance 
[5,11]. They are also more likely to endorse the use of non-recommended tests for follow up 
than are oncologists [15]. The SCP should clearly specify which physician is responsible for 
ordering which monitoring test. This will require clear guidelines from national professional 
organizations which incorporate input from oncologists and PCPs and define follow up 
monitoring and the role of the PCP in cancer survivor care. Oncology organizations should 
be encouraged to establishing clear guidelines delineating responsibility of cancer survivor 
care.
PCPs in practice a longer time expressed less understanding of the requirements for 
monitoring for late or chronic problems that result from cancer therapy. As cancer therapy 
has become more complex, primary care providers further from initial training may be 
unfamiliar with newer interventions and less aware of the current consequences of cancer 
therapy. Knowledge of the late and long term impact of cancer therapy is important for 
PCPs as patients may see them first about these symptoms and late and lingering effects may 
impact organ systems for which the patient is being monitored.
PCPs generally agreed that the detail in the SCP was adequate. However, PCP’s from the 
rural area were significantly less likely to agree that the SCP provided sufficient content to 
help them obtain tests for monitoring. Perhaps PCP’s in the urban area, who were often 
associated with an academic center, receive more cancer related education or presumed they 
had easier access to oncologists should questions arise. Additionally, actual monitoring 
recommendations may be less clearly defined than PCP’s anticipate and recommendations 
vary by cancer type which contributes to confusion about surveillance.
Insufficient knowledge of cancer survivor issues was a commonly identified barrier among 
PCPs and may partially explain why they felt the SCP provided insufficient detail. PCP 
uncertainty about late effects of cancer and follow up care recommendations has been 
identified by others [15]. Given the uncertainty PCPs have about late effects and what tests 
are needed for monitoring, continuing medical education should include more information 
about cancer therapy, long term and late effects of therapy, and surveillance of recurrence 
and new primary cancers.
Our findings have several limitations. The small sample size limits statistical power to detect 
small differences in responses by PCP characteristics. The use of a quantitative survey is 
also a limitation, as a qualitative approach may have provided a richer understanding of the 
complexities faced by PCPs when using information contained in a SCPs in a busy practice. 
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While the response rate was high, non-respondents may have differed in their assessment of 
the SCPs. Despite including PCPs practicing in both urban and rural areas, the survey was 
administered in a geographically localized area which limits generalizability of the study 
results. Participating PCPs in the urban area may be more integrated with the academic 
cancer center where most of their patients would receive oncologic care. They may also 
have more education opportunities and greater access to oncologists thus alleviating 
concerns about monitoring.
SCPs have the potential to strengthen communication, facilitate care coordination, clarify 
roles, and lessen PCPs anxiety about providing adequate care, thus increasing the 
opportunity for more primary care of cancer survivors. PCPs in rural and urban areas appear 
to find SCPs developed for their patients understandable and the content sufficiently detailed 
for most topics. However, usefulness of SCPs can be enhanced. Given the time challenges 
PCPs face SCP should as short and precise as possible. Clear delineation of roles between 
PCPs and oncologists and specific information within the SCP regarding late and long term 
effects and monitoring tests are needed. Oncology organizations should be encouraged to 
develop well-defined follow up recommendations. Ideally a SCP could be updated as new 
information regarding impacts of cancer treatment and follow up recommendations evolve. 
A disease and care management model that empowers patients, which improves health care 
team collaboration and patient outcomes has been found to be beneficial for patient with 
chronic disease [16] and would likely enhance cancer survivor care. This approach would be 
a particular advantage in rural settings by helping facilitate appropriate testing and 
communication with specialists. At a minimum, continuing education regarding cancer 
survivor issues will help relieve the dissonance PCPs may feel about assuming a larger role 
in cancer survivor care and their perception of insufficient knowledge of survivor issues and 
follow up.
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Table 1
Demographic data on responding primary care providers by practice setting.
Characteristic Urban (%) n=22 Rural (%) n=17
Specialty
Family Medicine 15 (68.2%) 13 (76.5%)
Internal Medicine 6 (27.3%) 2 (17.7%)
OB/Gyn 1 (4.6%) 0
NP/PA 0 1 (5.9%)
Gender
Male 11 (50%) 5 (29.4%)
Female 11 (50%) 12 (70.6%)
Median Years of Practice 17 (range 1–36) 20 (range 10–38)
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